Kane Biotech Inc. (CVE:KNE – Get Free Report)’s share price was up 8% during mid-day trading on Monday . The stock traded as high as C$0.15 and last traded at C$0.14. Approximately 31,500 shares changed hands during trading, a decline of 65% from the average daily volume of 89,338 shares. The stock had previously closed at C$0.13.
Kane Biotech Stock Up 3.7 %
The company has a debt-to-equity ratio of 1,164.24, a current ratio of 0.37 and a quick ratio of 0.39. The firm has a 50 day simple moving average of C$0.11 and a 200-day simple moving average of C$0.08. The stock has a market capitalization of C$18.46 million, a price-to-earnings ratio of -4.67 and a beta of 0.56.
Kane Biotech (CVE:KNE – Get Free Report) last released its quarterly earnings data on Tuesday, March 26th. The company reported C($0.01) earnings per share (EPS) for the quarter. The business had revenue of C$0.04 million during the quarter.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name.
Featured Articles
- Five stocks we like better than Kane Biotech
- What to Know About Investing in Penny Stocks
- Silicon Motion Proves That AI in Motion Stays in Motion
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Undervalued UnitedHealth Group Won’t Be For Long
- What Is WallStreetBets and What Stocks Are They Targeting?
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
